What are Integrated Care Systems and why should Pharma care?

The introduction of Integrated Care Systems (ICSs) in April 2022 is part of a fundamental shift in the way England’s health and care system is organised.

ICSs will see local authorities and local partners coming together to work with those who provide and commission NHS services across set geographical areas.

In coming together, the different agencies will work as a collective, setting the strategic direction and developing economies of scale to plan the health and care services needed by their geographies’ population of typically more than a million people.

“The central aim of ICSs is to integrate care across different organisations and settings, joining up hospital and community-based services, physical and mental health, and health and social care.”
(The King’s Fund)

What do ICSs mean for pharma?

The concept of joining up health and social care has been around for a long time. And now, the concept is becoming reality.

The vision is that ICSs will be the vehicle for the greater integration of health and care services:

  • improving population health and reducing inequalities
  • supporting productivity and sustainability of services
  • helping the NHS to support social and economic development

The move to ICS is targeted in its ambitions for what it wants to achieve in terms of better patient outcomes, better patient care and greater efficiencies.

But what do these changes mean for you as a pharma professional?

ICSs herald significant changes to the structure and dynamics of the health and care system across England.

“…much of the activity to integrate care and improve population health will be driven by commissioners and providers collaborating over smaller geographies within ICSs (often referred to as ‘places’) and through teams delivering services working together on even smaller footprints (usually referred to as ‘neighbourhoods’).
(The King’s Fund)

As changes to improve the efficiency of care are introduced, you will need effective analytics to map out the new territories and access the detailed data you need to grow your business.

Scott McKenzie, an Independent Management Consultant working inside the NHS, writes,

“It’s essential that pharma professionals have a detailed understanding of their local Integrated Care System (ICS) to best focus their time on the new NHS structure.”
(Scott McKenzie for Pharmafield)

And that’s where Inspiremed can help.

“By using analytics to map out the structure of the new Integrated care Systems, you’ll be able to see at-a-glance what’s changed in terms of your target audiences.”
(David Warwick, Director, Inspiremed)

Plan with confidence

Being able to see the structure of the new ICSs is going to be vital for pharma professionals. Access to data that reveals the structural changes that have taken place – and that continue to take place – will enable you to plan your accounts, marketing, and sales with confidence.

So, you can work more efficiently and effectively within the new structures.

Get in touch to find out how we can help you plan for the shift to ICSs.

Contact us 01600 891594 or email

“Our sales team use RX Analyser to analyse results and opportunity; it’s used by management to measure performance and identify national trends to drive targeting and strategy.”

National Sales Manager, UK Pharmaceutical Company

“I am extremely happy with the model and with the working relationship we have with Inspiremed.”

Country Manager UK, Leading Diagnostics Company

“The feature I like most? The ability to drill down to competitor sales.”

Senior Manager, Global Healthcare Company, 2016

“Budget impact calculation makes for a much more informed discussion with customers where cost savings are a key driver.”

Sales and Marketing Manager, Leading Healthcare Company, 2016

“Obviously I wouldn’t recommend Rx Analyser to our direct competitors as I believe the level of insight provided really gives us an edge.”

Sales and Marketing Manager, Leading Healthcare Company, 2016

“At a CCG level we can show our customers how we can work with individual surgeries to get substantial cost savings and utilize their budgets better. We work with medicines management teams to help them to save money whilst also improving outcomes.”

Country Manager UK, Leading Diagnostics Company

Sign up for added insights